Richard K Moussa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Venues

Expert review of pharmacoeconomics & outcomes research

The pharmacogenomics journal

National Statistics Institute

Université de Cergy-Pontoise (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Statistics Institute Nov 05 2019

Cote d'Ivoire

Associate researcher :: Economic Analysis Unit

ENSEA Nov 30 2012

Cote d'Ivoire

Assistant Professor

Institut National de la Statistique Nov 05 2011 - Feb 05 2014

Cote d'Ivoire

In charge of quaterly accounts :: National Accounts

Education History

Université de Cergy-Pontoise Sep 01 2014 - Dec 09 2016

France

PHD :: ThEMA

Institut National Polytechnique Félix Houphouët-Boigny Oct 01 2006 - Jun 30 2008

Cote d'Ivoire

BSC :: Ecole Préparatoire

Publications

Vakaramoko Diaby, Aram Babcock, Yushi Huang, Richard K Moussa, Paula S Espinal, Michelin Janvier, Diana Soler, Apeksha Gupta, Parul Jayakar, Magaly Diaz-Barbosa, Balagangadhar Totapally, Jun Sasaki, Anuj Jayakar, Daria Salyakina
Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States. The pharmacogenomics journal 22 (4) (2022)
Askal Ayalew Ali, Rima H Tawk, Hong Xiao, Anastasia Semykina, Alberto J Montero, Richard K Moussa, Olayiwola Popoola, Vakaramoko Diaby
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer. Expert review of pharmacoeconomics & outcomes research 22 (5) (2022)
Aram Babcock, Richard K Moussa, Vakaramoko Diaby
Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation. Expert review of pharmacoeconomics & outcomes research (2021)
Vakaramoko Diaby, Reem D Almutairi, Ziyan Chen, Richard K Moussa, Abdrahmane Berthe
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert review of pharmacoeconomics & outcomes research 21 (1) (2020)
Vakaramoko Diaby, Reem D Almutairi, Aram Babcock, Richard K Moussa, Askal Ayalew Ali
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)

Richard K Moussa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Richard K Moussa